Atomistry » Chlorine » PDB 5eie-5esh » 5en3
Atomistry »
  Chlorine »
    PDB 5eie-5esh »
      5en3 »

Chlorine in PDB 5en3: Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution

Protein crystallography data

The structure of Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution, PDB code: 5en3 was solved by A.Begum, L.Nilsson, A.Olofsson, A.E.Sauer-Eriksson, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 38.46 / 1.25
Space group P 21 21 2
Cell size a, b, c (Å), α, β, γ (°) 43.040, 85.625, 64.230, 90.00, 90.00, 90.00
R / Rfree (%) 13.4 / 15.8

Other elements in 5en3:

The structure of Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution also contains other interesting chemical elements:

Sodium (Na) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution (pdb code 5en3). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution, PDB code: 5en3:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 5en3

Go back to Chlorine Binding Sites List in 5en3
Chlorine binding site 1 out of 2 in the Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl201

b:39.9
occ:0.50
CL1 A:7LU201 0.0 39.9 0.5
C16 A:7LU201 1.7 45.6 0.5
HG1 A:THR119 1.9 21.4 0.5
HG A:SER117 1.9 22.2 0.4
HG A:SER117 2.0 17.9 0.2
OG1 A:THR119 2.7 17.9 0.5
C15 A:7LU201 2.7 48.7 0.5
C18 A:7LU201 2.7 47.5 0.5
OG A:SER117 2.7 18.5 0.4
OG A:SER117 2.8 15.0 0.2
HA A:THR118 2.8 18.2 1.0
H151 A:7LU201 2.8 58.5 0.5
H181 A:7LU201 2.8 57.0 0.5
HB3 A:SER117 3.0 19.7 0.4
O A:SER117 3.1 14.1 0.4
O A:SER117 3.1 14.5 0.2
C A:SER117 3.1 14.3 0.4
C A:SER117 3.1 14.3 0.2
N A:THR118 3.2 14.9 1.0
H A:THR119 3.2 17.7 0.5
CA A:THR118 3.2 15.2 1.0
C A:THR118 3.2 14.8 1.0
N A:THR119 3.3 14.7 0.5
HB A:THR119 3.3 16.9 0.5
HB2 A:SER117 3.3 19.7 0.4
C A:SER117 3.3 15.0 0.4
HB2 A:SER117 3.4 21.1 0.4
HB3 A:SER117 3.4 17.5 0.2
HB A:THR119 3.4 19.9 0.5
HG22 A:THR119 3.4 17.4 0.5
N A:THR119 3.4 13.9 0.5
CB A:SER117 3.5 16.4 0.4
CB A:SER117 3.5 17.6 0.4
H A:THR118 3.5 17.9 0.4
CB A:SER117 3.5 14.6 0.2
CB A:THR119 3.5 16.6 0.5
O A:SER117 3.6 15.3 0.4
H A:THR119 3.6 16.6 0.5
H A:THR118 3.7 17.9 0.2
H A:THR118 3.7 17.9 0.4
HG B:SER115 3.7 16.3 0.6
O A:THR118 3.9 17.1 1.0
HA A:ALA109 3.9 15.9 1.0
H A:LEU110 3.9 15.2 1.0
CB A:THR119 3.9 14.1 0.5
CA A:SER117 3.9 14.6 0.4
CA A:SER117 3.9 14.1 0.2
O A:ALA108 4.0 15.5 1.0
C14 A:7LU201 4.0 51.5 0.5
C19 A:7LU201 4.0 49.8 0.5
HB3 A:LEU110 4.0 18.2 1.0
CG2 A:THR119 4.1 14.5 0.5
CA A:SER117 4.1 15.3 0.4
CA A:THR119 4.1 13.9 0.5
CA A:THR119 4.2 14.1 0.5
HB2 A:LEU110 4.2 18.2 1.0
OG B:SER115 4.3 13.6 0.6
HG21 A:THR119 4.4 17.4 0.5
HB3 A:SER117 4.4 21.1 0.4
N A:LEU110 4.4 12.7 1.0
HB3 A:ALA108 4.4 21.3 1.0
O A:HOH312 4.4 53.9 0.5
HB2 A:SER117 4.4 17.5 0.2
HA A:SER117 4.5 16.9 0.2
HA A:SER117 4.5 17.5 0.4
C21 A:7LU201 4.5 51.7 0.5
HB2 B:SER115 4.5 21.1 0.4
HA A:THR119 4.5 16.7 0.5
CB A:LEU110 4.5 15.1 1.0
C A:ALA108 4.5 13.8 1.0
CA A:ALA109 4.6 13.3 1.0
HA A:THR119 4.7 16.9 0.5
HA A:SER117 4.7 18.4 0.4
CB A:THR118 4.7 16.4 1.0
H A:SER117 4.8 17.0 0.4
CG2 A:THR119 4.8 17.2 0.5
OG A:SER117 4.8 18.4 0.4
C A:ALA109 4.9 13.7 1.0
H A:SER117 4.9 16.7 0.4
HB1 A:ALA108 4.9 21.3 1.0
H A:SER117 4.9 16.5 0.2
HG21 A:THR119 4.9 20.7 0.5
N A:ALA109 4.9 13.2 1.0
H201 A:7LU201 4.9 59.9 0.5
HG23 A:THR119 4.9 17.4 0.5

Chlorine binding site 2 out of 2 in 5en3

Go back to Chlorine Binding Sites List in 5en3
Chlorine binding site 2 out of 2 in the Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Human Transthyretin in Complex with Luteolin-Cl at 1.25 A Resolution within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Cl201

b:28.2
occ:0.50
CL1 B:7LU201 0.0 28.2 0.5
C16 B:7LU201 1.7 30.5 0.5
HG1 B:THR119 1.9 22.2 0.4
HG B:SER117 2.1 18.3 0.2
OG1 B:THR119 2.6 18.5 0.4
OG B:SER117 2.7 18.2 0.4
C15 B:7LU201 2.7 32.1 0.5
C18 B:7LU201 2.7 29.8 0.5
H151 B:7LU201 2.8 38.5 0.5
H181 B:7LU201 2.8 35.7 0.5
OG B:SER117 2.8 15.3 0.2
HA B:THR118 2.9 18.5 1.0
HB3 B:SER117 2.9 20.4 0.4
O B:SER117 3.1 14.5 0.4
C B:SER117 3.1 14.4 0.4
C B:SER117 3.1 14.4 0.2
O B:SER117 3.2 14.7 0.2
HG B:SER117 3.2 21.9 0.4
N B:THR118 3.2 15.0 1.0
HB3 B:SER117 3.2 17.9 0.2
H B:THR119 3.3 17.4 0.6
HB B:THR119 3.3 17.9 0.6
C B:THR118 3.3 15.3 1.0
CA B:THR118 3.3 15.4 1.0
N B:THR119 3.3 14.5 0.6
HB2 B:SER117 3.3 20.4 0.4
HB2 B:SER117 3.3 20.8 0.4
C B:SER117 3.3 15.4 0.4
HG22 B:THR119 3.4 18.6 0.6
HB B:THR119 3.5 20.8 0.4
CB B:SER117 3.5 14.9 0.2
N B:THR119 3.5 14.2 0.4
CB B:SER117 3.5 17.0 0.4
CB B:SER117 3.5 17.3 0.4
CB B:THR119 3.6 17.3 0.4
H B:THR118 3.6 18.1 0.4
O B:SER117 3.6 15.5 0.4
H B:THR119 3.7 17.0 0.4
H B:THR118 3.7 18.1 0.2
H B:THR118 3.7 18.1 0.4
O B:THR118 3.9 16.7 1.0
H B:LEU110 3.9 15.8 1.0
HA B:ALA109 3.9 17.8 1.0
CA B:SER117 3.9 14.2 0.2
CA B:SER117 3.9 14.7 0.4
CB B:THR119 3.9 14.9 0.6
C14 B:7LU201 4.0 33.7 0.5
C19 B:7LU201 4.0 31.6 0.5
HB3 B:LEU110 4.0 16.8 1.0
CG2 B:THR119 4.0 15.5 0.6
CA B:SER117 4.0 15.8 0.4
O B:ALA108 4.1 15.7 1.0
CA B:THR119 4.1 15.0 0.4
HB2 B:LEU110 4.2 16.8 1.0
CA B:THR119 4.2 14.6 0.6
OG A:SER115 4.2 21.2 1.0
HG21 B:THR119 4.3 18.6 0.6
HB3 B:SER117 4.3 20.8 0.4
HB2 B:SER117 4.4 17.9 0.2
N B:LEU110 4.4 13.2 1.0
HA B:SER117 4.4 17.0 0.2
HA B:SER117 4.5 17.6 0.4
HG A:SER115 4.5 25.4 1.0
O B:HOH314 4.5 30.7 0.5
C21 B:7LU201 4.5 33.6 0.5
CB B:LEU110 4.5 14.0 1.0
HA B:THR119 4.6 18.0 0.4
HB3 B:ALA108 4.6 21.1 1.0
C B:ALA108 4.7 15.0 1.0
CA B:ALA109 4.7 14.8 1.0
HA B:SER117 4.7 19.0 0.4
HA B:THR119 4.7 17.5 0.6
CB B:THR118 4.8 16.8 1.0
OG B:SER117 4.8 18.1 0.4
CG2 B:THR119 4.8 18.1 0.4
H B:SER117 4.8 17.3 0.4
HG21 B:THR119 4.8 21.7 0.4
H B:SER117 4.9 16.5 0.4
H B:SER117 4.9 16.3 0.2
HG23 B:THR119 4.9 18.6 0.6
C B:ALA109 4.9 13.7 1.0
HG B:SER117 4.9 21.7 0.4
H201 B:7LU201 4.9 36.8 0.5
N B:ALA109 5.0 14.1 1.0
N B:SER117 5.0 13.8 0.4
N B:SER117 5.0 13.6 0.2
N B:SER117 5.0 14.4 0.4

Reference:

L.Nilsson, A.Larsson, A.Begum, I.Iakovleva, M.Carlsson, K.Brannstrom, A.E.Sauer-Eriksson, A.Olofsson. Modifications of the 7-Hydroxyl Group of the Transthyretin Ligand Luteolin Provide Mechanistic Insights Into Its Binding Properties and High Plasma Specificity. Plos One V. 11 53112 2016.
ISSN: ESSN 1932-6203
PubMed: 27050398
DOI: 10.1371/JOURNAL.PONE.0153112
Page generated: Sat Jul 12 01:45:10 2025

Last articles

Fe in 4UQH
Fe in 4UPT
Fe in 4UPS
Fe in 4UPR
Fe in 4UPQ
Fe in 4UPP
Fe in 4UPO
Fe in 4UOB
Fe in 4UNF
Fe in 4UPN
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy